Physician profile
Jorge Reyes
NPI 1457804759
$2,943.74
in general payments reported to CMS, 2019-2025
13 companies · $200 in 2025
The $200 reported for 2025 was more than what 75% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $38.35 · 2021: $315 · 2022: $13.51 · 2023: $110 · 2024: $1,166 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,123 · Food and Beverage: $225 · Gift: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,123.28 |
| Food and Beverage | $224.63 |
| Gift | $128.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $1,162.50 | 2019-2021 | |
| Biosense Webster, INC. | $1,123.28 | 2024 | |
| Ultradent Products INC | $128.49 | 2025 | Opalescence |
| Henry Schein, INC. | $99.91 | 2019 | |
| Straumann USA LLC | $75.00 | 2019 | |
| Dentsply Sirona INC | $70.97 | 2019-2024 | Atlantis |
| Align Technology, INC. | $64.73 | 2022-2023 | Invisalign Go, Itero Element 5d Plus |
| Premier Dental Products Company | $49.90 | 2019 | |
| Solventum Corporation | $45.34 | 2025 | Clarity Aligners, Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Nobel Biocare USA | $44.11 | 2020-2023 | Nobelactive |
| 3m Company | $32.18 | 2020-2023 | 3m Relyx, 3m, Scotchbond Universal Plus |
| Geistlich Pharma, North America, INC. | $26.40 | 2025 | Biomaterials |
| Kerr Corporation | $20.93 | 2023 | Nexus Rmgi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.